(R,S)-Montelukast Bis-sulfide | Montelukast EP impurity E | 2-[1-[[(1R)-1-[3-[(1S)-1-[[1-(carboxymethyl)cyclopropyl]methylsulfanyl]-2-(7-chloroquinolin-2-yl)ethyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
(R,S)-Montelukast Bis-sulfide
Montelukast EP impurity E
2-[1-[[(1R)-1-[3-[(1S)-1-[[1-(carboxymethyl)cyclopropyl]methylsulfanyl]-2-(7-chloroquinolin-2-yl)ethyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
TL51FC9FWV
Montelukast impurity E (R,S)
Computed Properties
Structural Parameters
Heavy atom count
50
Aromatic heavy atom count
22
Fraction Csp3
0.44
Rotatable bonds
18
H-bond acceptors
6
H-bond donors
3
Molar refractivity
205.14
TPSA
107.72
LogP / Solubility
WLOGP
10.05
MLOGP
8.91
XLogP3
8
Consensus LogP
8.99
Log S (ESOL)
-9.85
Class (ESOL)
Insoluble
Log S (Ali)
-12.82
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-14.92
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-0.05
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
6.5
Customers Also Viewed
Montelukast Bis-sulfide (Mixture of Diastereomers)